Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Pharmaceuticals ETF

+ Add to Watchlist

XPH:US

121.6500 USD 1.8700 1.51%

As of 12:43:41 ET on 04/01/2015.

Snapshot for SPDR S&P Pharmaceuticals ETF (XPH)

Open: 123.1800 High - Low: 123.2958 - 120.5270 Primary Exchange: NYSE Arca
Volume: 48,592 52-Week Range: 81.4015 - 132.5500 Beta vs SPSIPHTR: 1.0026

ETF Chart for XPH

No chart data available.
  • XPH:US 121.6500
  • 1D
  • 1M
  • 1Y
123.5200
Interactive XPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XPH

SPDR Pharmaceuticals ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Pharmaceuticals Select Industry Index, an equal-weighted index.

Inception Date: 2006-06-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XPH

NAV (on 2015-03-31) 123.4579
Assets (M) (on 2015-03-31) 1,197.5580
Shares out (M) 9.70
Market Cap (M) 1,178.86
% Premium 0.05
Average 52-Week % Premium 0.0233
Fund Leveraged N

Dividends for XPH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-20) 0.2082
Dividend Yield (ttm) 4.99%

Performance for XPH

1-Month +0.03% 1-Year +39.21%
3-Month +14.60% 3-Year +33.36%
Year To Date +14.60% 5-Year +26.86%
Expense Ratio 0.35

Top Fund Holdings for XPH

Filing Date: 03/31/2015
Name Position Value % of Total
Horizon Pharma Plc 1,616,514 41,980,869 3.506%
Akorn Inc 879,915 41,804,762 3.491%
Lannett Co Inc 558,547 37,819,217 3.158%
Eli Lilly & Co 519,715 37,757,295 3.153%
ANI Pharmaceuticals Inc 602,038 37,657,477 3.145%
Impax Laboratories Inc 802,386 37,607,832 3.141%
Endo International PLC 415,869 37,303,449 3.115%
Pfizer Inc 1,068,318 37,166,783 3.104%
Merck & Co Inc 646,322 37,150,589 3.102%
Mallinckrodt PLC 292,594 37,057,030 3.095%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil